(Q33498058)

27 July 2017

title

Haemolytic uraemic syndrome in a patient with lung cancer: further evidence for a toxic interaction between mitomycin-C and tamoxifen (English)

1 reference

27 July 2017

1 reference

Ellis PA

1

1 reference

27 July 2017

Luckitt J

series ordinal

2

1 reference

27 July 2017

Treleaven J

series ordinal

3

1 reference

27 July 2017

Smith IE

series ordinal

4

1 reference

27 July 2017

publication date

1 January 1996

1 reference

27 July 2017

1 reference

27 July 2017

volume

8

1 reference

27 July 2017

issue

6

1 reference

27 July 2017

page(s)

402-403

1 reference

Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2896%2980093-8

Crossref

reference URL

inferred from DOI database lookup

7 January 2021

based on heuristic

A toxic interaction between mitomycin C and tamoxifen causing the haemolytic uraemic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2896%2980093-8

Crossref

reference URL

inferred from DOI database lookup

7 January 2021

based on heuristic

A pilot study of mitomycin, cisplatin and continuous infusion 5-fluorouracil (MCF) in advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2896%2980093-8

Crossref

reference URL

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0936-6555(96)80093-8

1 reference

27 July 2017

1 reference